Generali Asset Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$790K Buy
6,508
+368
+6% +$44.9K 0.01% 344
2026
Q2
$696K Sell
6,140
-10,965
-64% -$1.09M 0.01% 373
2026
Q1
$1.61M Buy
17,105
+2,332
+16% +$233K 0.03% 333
2025
Q4
$1.46M Sell
14,773
-9,881
-40% -$956K 0.03% 359
2025
Q3
$2.09M Sell
24,654
-6,280
-20% -$496K 0.04% 300
2025
Q2
$2.11M Buy
30,934
+14,943
+93% +$947K 0.05% 297
2025
Q1
$968K Sell
15,991
-22,496
-58% -$1.57M 0.02% 388
2024
Q4
$2.66M Buy
+38,487
New +$2.74M 0.07% 278

Other funds holding INCY

Generali Asset Management's INCY Position: Q3 2026 in Review

Generali Asset Management increased its Incyte (INCY) stake by 6% in Q3 2026, buying an estimated $44.9K and bringing the position to 6,508 shares worth $790K. The position accounts for 0.01% of the portfolio, ranked #344.

Generali Asset Management first reported a position in INCY in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.66M in Q4 2024. 450 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • Generali Asset Management held 6,508 shares of Incyte worth $790K as of Q3 2026.
  • Generali Asset Management bought 368 Incyte shares in Q3 2026, an estimated $44.9K.
  • Incyte made up 0.01% of Generali Asset Management's portfolio in Q3 2026, its #344 holding.
  • Generali Asset Management first reported a position in Incyte in Q4 2024 and has held it in 8 quarters since.
  • Generali Asset Management's Incyte position peaked at $2.66M in Q4 2024.
  • 450 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on Generali Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.